BRC investment was used to fund part of consultant salaries and to support the breast BRC programme of translational research (prognostic and predictive markers and prognostic tools; breast stem cells; monitoring of tumour responses with functional/molecular imaging; translational neoadjuvant studies; novel radiotherapy protocols).
The breast programme in the Cambridge BRC has continued to generate translational research (29 publications in 04-2009/03-2010) that is having a direct impact on NHS-patient management by improved approaches to diagnosis, prognosis and therapy.
Section:
Cancer
